Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antenatal betamethasone before elective term cesarean section to prevent neonatal respiratory distress
IRCT20121224011862N3Phase 2Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jun 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of betamethasone in respiratory distress syndrome (RDS) (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoints: Neonatal respiratory outcomes, Need for NICU care and 1 more. Started Jun 2019; status: completed.
02
Drugs
betamethasone
03
Conditions
respiratory distress syndrome (RDS)
Beyond the preview
Go deeper on IRCT20121224011862N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20121224011862N3.